Lim HI, Yamamoto J, Inubushi S, Nishino H, et al. A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model. Anticancer Res 2020;40:2481-2485.
PMID: 32366392